Currently out of the existing stock ratings of Jim Molloy, 38 are a BUY (92.68%), 2 are a SELL (4.88%), 1 are a HOLD (2.44%).

Jim Molloy

Work Performance Price Targets & Ratings Chart

Analyst Jim Molloy works at ALLIANCE GLOBAL PARTNERS with a stock forecast success ratio of 39.91% fulfilled within 56.18 days on average.

Jim Molloy’s has documented 77 price targets and ratings displayed on 15 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on TNXP, Tonix Pharmaceuticals Holding Corp at 01-Aug-2023.

Wall Street Analyst Jim Molloy

Analyst best performing recommendations are on TNXP (TONIX PHARMACEUTICALS HOLDING CORP).
The best stock recommendation documented was for TNXP (TONIX PHARMACEUTICALS HOLDING CORP) at 1/12/2023. The price target of $6.5 was fulfilled within 6 days with a profit of $1 (13.33%) receiving and performance score of 22.22.

Average potential price target upside

ICPT Intercept Pharmaceuticals HTBX Heat Biologics . TNXP Tonix Pharmaceuticals Holding Corp ALIM Alimera Sciences AQST Aquestive Therapeutics BCDA Biocardia  CANF Can Fite Biopharma Ltd ADR ENVB Enveric Biosciences ETTX Entasis Therapeutics Holdings NHWK Nighthawk Biosciences OCUP Ocuphire Pharma ORMP Oramed Pharmaceuticals PSTI Pluristem SLS Sellas Life Sciences Group SNGX Soligenix

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

19

20

4 months 28 days ago

3/8 (37.5%)

$0.42 (2.26%)

63

Hold

19

19

4 months 28 days ago

5/5 (100%)

$0.42 (2.26%)

66

Hold

19

13

4 months 28 days ago

12/24 (50%)

$0.42 (2.26%)

40

Hold

19

15

4 months 28 days ago

3/14 (21.43%)

$0.42 (2.26%)

57

Hold

26

9 months 1 days ago

0/4 (0%)

$5.32 (25.73%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Jim Molloy?

On 2014

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?